English

SEATTLE GENETICS INC /WA

EDGAR

SGEN Quarterly report (10-Q) · filed 2023-11-01

147 filing records in this dataset, filed from 2001-05-14 to 2023-11-01. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

649 million USD

2023 Q3 · USD

Exact inputs and evidence

Revenue: 648650000 USD Source

Operating margin

-35.66%

2023 Q3 · %

Exact inputs and evidence

Operating Income: -231338000 USD Source
Revenue: 648650000 USD Source

Operating cash flow

-35.8 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -460711000 USD Source
Operating Cash Flow: -424888000 USD Source

Free cash flow

-79.8 million USD

2023 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -460711000 USD Source
Operating Cash Flow: -424888000 USD Source
Capital Expenditure: 131815000 USD Source
Capital Expenditure: 87885000 USD Source

Cash and cash equivalents: 429 million USD 2023-09-30 Source
Exact value

428568000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 189 million shares 2023-09-30 Source
Exact value

188628000 shares

Reported share-count change

1.83% · 3.39 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

185234000 shares · 2022-09-30· Source
188628000 shares · 2023-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

2.3 billion USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Revenue: 1962412000 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 1434262000 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 519719000 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 603832000 USD · 2023-04-01 – 2023-06-30 Source
Revenue: 648650000 USD · 2023-07-01 – 2023-09-30 Source

Net income

-750 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Net income: -610308000 USD · 2022-01-01 – 2022-12-31 Source
Net income: -462137000 USD · 2022-01-01 – 2022-09-30 Source
Net income: -174737000 USD · 2023-01-01 – 2023-03-31 Source
Net income: -211528000 USD · 2023-04-01 – 2023-06-30 Source
Net income: -215789000 USD · 2023-07-01 – 2023-09-30 Source

Operating cash flow

-540 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -453751000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -374311000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -249643000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -424888000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -249643000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -460711000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -424888000 USD · 2023-01-01 – 2023-06-30 Source

Capital expenditure

161 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Capital expenditure: 77340000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 48095000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 38655000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 87885000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 38655000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 131815000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 87885000 USD · 2023-01-01 – 2023-06-30 Source

Free cash flow

-701 million USD

2022-10-01 – 2023-09-30

Exact inputs and evidence

Operating cash flow: -453751000 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -374311000 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -249643000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -424888000 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -249643000 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: -460711000 USD · 2023-01-01 – 2023-09-30 Source
Operating cash flow: -424888000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 77340000 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 48095000 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 38655000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 87885000 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 38655000 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 131815000 USD · 2023-01-01 – 2023-09-30 Source
Capital expenditure: 87885000 USD · 2023-01-01 – 2023-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-11-01.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2022-12-31
Operating income: 11 of 11 periods available· newest 2022-12-31
Net income: 11 of 11 periods available· newest 2022-12-31
Operating cash flow: 11 of 11 periods available· newest 2022-12-31
Capital expenditure: 11 of 11 periods available· newest 2022-12-31
Total assets: 11 of 11 periods available· newest 2022-12-31
liabilities: No compatible figures in this window
Current assets: 11 of 11 periods available· newest 2022-12-31
Current liabilities: 11 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2022-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+24.6%

Prior period

USD 1.57 billion

2021-01-01 – 2021-12-31
Current period

USD 1.96 billion

2022-01-01 – 2022-12-31

Exact inputs and evidence

1962412000 − 1574371000 = 388041000 USD

1574371000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
1962412000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Year-over-year change in Revenue: 388041000 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1962412000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1723475 Filing: 000106073623000009 Input fundies:Revenue: 1574371000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1724856 Filing: 000106073623000009
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 64.16 million

Prior period

−USD 674.47 million

2021-01-01 – 2021-12-31
Current period

−USD 610.31 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-610308000 − -674471000 = 64163000 USD

-674471000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-610308000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Year-over-year change in Net income: 64163000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -610308000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#2220813 Filing: 000106073623000009 Input fundies:NetIncome: -674471000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#2222077 Filing: 000106073623000009
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 45.26 million

Prior period

−USD 499.01 million

2021-01-01 – 2021-12-31
Current period

−USD 453.75 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

-453751000 − -499007000 = 45256000 USD

-499007000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
-453751000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Year-over-year change in Operating cash flow: 45256000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -453751000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1478938 Filing: 000106073623000009 Input fundies:OperatingCashFlow: -499007000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1479996 Filing: 000106073623000009
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+47.8%

Prior period

USD 52.33 million

2021-01-01 – 2021-12-31
Current period

USD 77.34 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

77340000 − 52330000 = 25010000 USD

52330000 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
77340000 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Year-over-year change in Capital expenditure: 25010000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 77340000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1496207 Filing: 000106073623000009 Input fundies:CapitalExpenditure: 52330000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1497197 Filing: 000106073623000009
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 1.96 billion 100% of revenue
Cost of revenue USD 410.06 million 21% of revenue
Operating expenses USD 2.17 billion 110% of revenue
Operating income −USD 612.97 million −31% of revenue
Tax, interest and other Derived −USD 2.66 million −0.1% of revenue
Net income −USD 610.31 million −31% of revenue

Cash

Operating cash flow −USD 453.75 million −23% of revenue
Capital expenditure USD 77.34 million 3.9% of revenue
Free cash flow Derived −USD 531.09 million −27% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2013 Operating loss: operating costs were 123% of revenue.
2014 Operating loss: operating costs were 127% of revenue.
2015 Operating loss: operating costs were 136% of revenue.
2016 Operating loss: operating costs were 134% of revenue.
2017 Operating loss: operating costs were 141% of revenue.
2018 Operating loss: operating costs were 140% of revenue.
2019 Operating loss: operating costs were 124% of revenue.
2020 Net income was higher than operating income, so the split is not drawn.
2021 Operating loss: operating costs were 143% of revenue.
2022 Operating loss: operating costs were 131% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2013 2013-01-01 – 2013-12-31	269264000	332125000 Derived	-62861000	-341000 Derived	-62520000	-23264000 Derived	Source 2013-01-01 – 2013-12-31: 269264000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -62861000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -62520000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -1110000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 22154000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	286758000	364121000 Derived	-77363000	-1222000 Derived	-76141000	-77175000 Derived	Source 2014-01-01 – 2014-12-31: 286758000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -77363000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -76141000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -59999000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 17176000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	336802000	457752000 Derived	-120950000	-464000 Derived	-120486000	-146595000 Derived	Source 2015-01-01 – 2015-12-31: 336802000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -120950000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -120486000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -133203000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 13392000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	418147000	560872000 Derived	-142725000	-2614000 Derived	-140111000	-124806000 Derived	Source 2016-01-01 – 2016-12-31: 418147000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -142725000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -140111000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -96971000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 27835000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	482250000	678051000 Derived	-195801000	-70271000 Derived	-125530000	-147622000 Derived	Source 2017-01-01 – 2017-12-31: 482250000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -195801000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -125530000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -118900000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 28722000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	654700000	914698000 Derived	-259998000	-37305000 Derived	-222693000	-224755000 Derived	Source 2018-01-01 – 2018-12-31: 654700000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -259998000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -222693000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -203536000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 21219000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	916713000	1137258000 Derived	-220545000	-61895000 Derived	-158650000	-234490000 Derived	Source 2019-01-01 – 2019-12-31: 916713000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -220545000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -158650000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -163737000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 70753000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	2175536000	1578684000 Derived	596852000	-16818000 Derived	613670000	774159000 Derived	Source 2020-01-01 – 2020-12-31: 2175536000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 596852000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: 613670000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 856568000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 82409000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	1574371000	2256427000 Derived	-682056000	-7585000 Derived	-674471000	-551337000 Derived	Source 2021-01-01 – 2021-12-31: 1574371000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -682056000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -674471000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -499007000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 52330000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	1962412000	2575382000 Derived	-612970000	-2662000 Derived	-610308000	-531091000 Derived	Source 2022-01-01 – 2022-12-31: 1962412000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -612970000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -610308000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -453751000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 77340000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2B 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Revenue	269264000	Revenue: 269264000 Open source
20142014-12-31	Revenue	286758000	Revenue: 286758000 Open source
20152015-12-31	Revenue	336802000	Revenue: 336802000 Open source
20162016-12-31	Revenue	418147000	Revenue: 418147000 Open source
20172017-12-31	Revenue	482250000	Revenue: 482250000 Open source
20182018-12-31	Revenue	654700000	Revenue: 654700000 Open source
20192019-12-31	Revenue	916713000	Revenue: 916713000 Open source
20202020-12-31	Revenue	2175536000	Revenue: 2175536000 Open source
20212021-12-31	Revenue	1574371000	Revenue: 1574371000 Open source
20222022-12-31	Revenue	1962412000	Revenue: 1962412000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

24.6% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Year over year	27.7%	Revenue: 269264000 Open source Revenue: 210812000 Open source
20142014-12-31	Year over year	6.5%	Revenue: 286758000 Open source Revenue: 269264000 Open source
20152015-12-31	Year over year	17.5%	Revenue: 336802000 Open source Revenue: 286758000 Open source
20162016-12-31	Year over year	24.2%	Revenue: 418147000 Open source Revenue: 336802000 Open source
20172017-12-31	Year over year	15.3%	Revenue: 482250000 Open source Revenue: 418147000 Open source
20182018-12-31	Year over year	35.8%	Revenue: 654700000 Open source Revenue: 482250000 Open source
20192019-12-31	Year over year	40%	Revenue: 916713000 Open source Revenue: 654700000 Open source
20202020-12-31	Year over year	137.3%	Revenue: 2175536000 Open source Revenue: 916713000 Open source
20212021-12-31	Year over year	-27.6%	Revenue: 1574371000 Open source Revenue: 2175536000 Open source
20222022-12-31	Year over year	24.6%	Revenue: 1962412000 Open source Revenue: 1574371000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -31.2% 2022

Net margin -31.1% 2022

Free cash flow margin -27.1% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Operating margin	-23.3%	Operating Income: -62861000 Open source Revenue: 269264000 Open source
20142014-12-31	Operating margin	-27%	Operating Income: -77363000 Open source Revenue: 286758000 Open source
20152015-12-31	Operating margin	-35.9%	Operating Income: -120950000 Open source Revenue: 336802000 Open source
20162016-12-31	Operating margin	-34.1%	Operating Income: -142725000 Open source Revenue: 418147000 Open source
20172017-12-31	Operating margin	-40.6%	Operating Income: -195801000 Open source Revenue: 482250000 Open source
20182018-12-31	Operating margin	-39.7%	Operating Income: -259998000 Open source Revenue: 654700000 Open source
20192019-12-31	Operating margin	-24.1%	Operating Income: -220545000 Open source Revenue: 916713000 Open source
20202020-12-31	Operating margin	27.4%	Operating Income: 596852000 Open source Revenue: 2175536000 Open source
20212021-12-31	Operating margin	-43.3%	Operating Income: -682056000 Open source Revenue: 1574371000 Open source
20222022-12-31	Operating margin	-31.2%	Operating Income: -612970000 Open source Revenue: 1962412000 Open source
20132013-12-31	Net margin	-23.2%	Net Income: -62520000 Open source Revenue: 269264000 Open source
20142014-12-31	Net margin	-26.6%	Net Income: -76141000 Open source Revenue: 286758000 Open source
20152015-12-31	Net margin	-35.8%	Net Income: -120486000 Open source Revenue: 336802000 Open source
20162016-12-31	Net margin	-33.5%	Net Income: -140111000 Open source Revenue: 418147000 Open source
20172017-12-31	Net margin	-26%	Net Income: -125530000 Open source Revenue: 482250000 Open source
20182018-12-31	Net margin	-34%	Net Income: -222693000 Open source Revenue: 654700000 Open source
20192019-12-31	Net margin	-17.3%	Net Income: -158650000 Open source Revenue: 916713000 Open source
20202020-12-31	Net margin	28.2%	Net Income: 613670000 Open source Revenue: 2175536000 Open source
20212021-12-31	Net margin	-42.8%	Net Income: -674471000 Open source Revenue: 1574371000 Open source
20222022-12-31	Net margin	-31.1%	Net Income: -610308000 Open source Revenue: 1962412000 Open source
20132013-12-31	Free cash flow margin	-8.6%	Revenue: 269264000 Open source Operating Cash Flow: -1110000 Open source Capital Expenditure: 22154000 Open source
20142014-12-31	Free cash flow margin	-26.9%	Revenue: 286758000 Open source Operating Cash Flow: -59999000 Open source Capital Expenditure: 17176000 Open source
20152015-12-31	Free cash flow margin	-43.5%	Revenue: 336802000 Open source Operating Cash Flow: -133203000 Open source Capital Expenditure: 13392000 Open source
20162016-12-31	Free cash flow margin	-29.8%	Revenue: 418147000 Open source Operating Cash Flow: -96971000 Open source Capital Expenditure: 27835000 Open source
20172017-12-31	Free cash flow margin	-30.6%	Revenue: 482250000 Open source Operating Cash Flow: -118900000 Open source Capital Expenditure: 28722000 Open source
20182018-12-31	Free cash flow margin	-34.3%	Revenue: 654700000 Open source Operating Cash Flow: -203536000 Open source Capital Expenditure: 21219000 Open source
20192019-12-31	Free cash flow margin	-25.6%	Revenue: 916713000 Open source Operating Cash Flow: -163737000 Open source Capital Expenditure: 70753000 Open source
20202020-12-31	Free cash flow margin	35.6%	Revenue: 2175536000 Open source Operating Cash Flow: 856568000 Open source Capital Expenditure: 82409000 Open source
20212021-12-31	Free cash flow margin	-35%	Revenue: 1574371000 Open source Operating Cash Flow: -499007000 Open source Capital Expenditure: 52330000 Open source
20222022-12-31	Free cash flow margin	-27.1%	Revenue: 1962412000 Open source Operating Cash Flow: -453751000 Open source Capital Expenditure: 77340000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -453.8M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Operating cash flow	-1110000	Operating Cash Flow: -1110000 Open source
20142014-12-31	Operating cash flow	-59999000	Operating Cash Flow: -59999000 Open source
20152015-12-31	Operating cash flow	-133203000	Operating Cash Flow: -133203000 Open source
20162016-12-31	Operating cash flow	-96971000	Operating Cash Flow: -96971000 Open source
20172017-12-31	Operating cash flow	-118900000	Operating Cash Flow: -118900000 Open source
20182018-12-31	Operating cash flow	-203536000	Operating Cash Flow: -203536000 Open source
20192019-12-31	Operating cash flow	-163737000	Operating Cash Flow: -163737000 Open source
20202020-12-31	Operating cash flow	856568000	Operating Cash Flow: 856568000 Open source
20212021-12-31	Operating cash flow	-499007000	Operating Cash Flow: -499007000 Open source
20222022-12-31	Operating cash flow	-453751000	Operating Cash Flow: -453751000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -531.1M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20132013-12-31	Free cash flow	-23264000	Operating Cash Flow: -1110000 Open source Capital Expenditure: 22154000 Open source
20142014-12-31	Free cash flow	-77175000	Operating Cash Flow: -59999000 Open source Capital Expenditure: 17176000 Open source
20152015-12-31	Free cash flow	-146595000	Operating Cash Flow: -133203000 Open source Capital Expenditure: 13392000 Open source
20162016-12-31	Free cash flow	-124806000	Operating Cash Flow: -96971000 Open source Capital Expenditure: 27835000 Open source
20172017-12-31	Free cash flow	-147622000	Operating Cash Flow: -118900000 Open source Capital Expenditure: 28722000 Open source
20182018-12-31	Free cash flow	-224755000	Operating Cash Flow: -203536000 Open source Capital Expenditure: 21219000 Open source
20192019-12-31	Free cash flow	-234490000	Operating Cash Flow: -163737000 Open source Capital Expenditure: 70753000 Open source
20202020-12-31	Free cash flow	774159000	Operating Cash Flow: 856568000 Open source Capital Expenditure: 82409000 Open source
20212021-12-31	Free cash flow	-551337000	Operating Cash Flow: -499007000 Open source Capital Expenditure: 52330000 Open source
20222022-12-31	Free cash flow	-531091000	Operating Cash Flow: -453751000 Open source Capital Expenditure: 77340000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2013-12-31	Liabilities / assets	Not reported	Total Assets: 483898000 Open source
2014-12-31	Liabilities / assets	Not reported	Total Assets: 458965000 Open source
2015-12-31	Liabilities / assets	Not reported	Total Assets: 895095000 Open source
2016-12-31	Liabilities / assets	Not reported	Total Assets: 838396000 Open source
2017-12-31	Liabilities / assets	Not reported	Total Assets: 877949000 Open source
2018-12-31	Liabilities / assets	Not reported	Total Assets: 1503329000 Open source
2019-12-31	Liabilities / assets	Not reported	Total Assets: 2205866000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 4000906000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 3719604000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 3674532000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.42× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20132013-12-31	Current assets / current liabilities	4.41×	Current Assets: 437256000 Open source Current Liabilities: 99198000 Open source
20142014-12-31	Current assets / current liabilities	3.24×	Current Assets: 407986000 Open source Current Liabilities: 125893000 Open source
20152015-12-31	Current assets / current liabilities	5.74×	Current Assets: 771059000 Open source Current Liabilities: 134266000 Open source
20162016-12-31	Current assets / current liabilities	4.95×	Current Assets: 734648000 Open source Current Liabilities: 148516000 Open source
20172017-12-31	Current assets / current liabilities	3.45×	Current Assets: 577061000 Open source Current Liabilities: 167129000 Open source
20182018-12-31	Current assets / current liabilities	2.9×	Current Assets: 653595000 Open source Current Liabilities: 225072000 Open source
20192019-12-31	Current assets / current liabilities	4.54×	Current Assets: 1176641000 Open source Current Liabilities: 259357000 Open source
20202020-12-31	Current assets / current liabilities	7.89×	Current Assets: 3062384000 Open source Current Liabilities: 388138000 Open source
20212021-12-31	Current assets / current liabilities	5.04×	Current Assets: 2869194000 Open source Current Liabilities: 568854000 Open source
20222022-12-31	Current assets / current liabilities	3.42×	Current Assets: 2802533000 Open source Current Liabilities: 818404000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2013 2013-01-01 – 2013-12-31	−USD 62.52 million Exact value Exact value: -62520000 USD 2013-01-01 – 2013-12-31: -62520000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2013-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -62520000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62520000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312516470022/sgen-20151231.xml#73169 Filing: 000119312516470022 The citation records this snapshot. The page link may show a newer release later.	−USD 1.11 million Exact value Exact value: -1110000 USD 2013-01-01 – 2013-12-31: -1110000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2013-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -1110000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1110000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312516470022/sgen-20151231.xml#70616 Filing: 000119312516470022 The citation records this snapshot. The page link may show a newer release later.	USD 22.15 million Exact value Exact value: 22154000 USD 2013-01-01 – 2013-12-31: 22154000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2013-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 22154000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22154000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312516470022/sgen-20151231.xml#72902 Filing: 000119312516470022 The citation records this snapshot. The page link may show a newer release later.	−USD 23.26 million Calculation and evidence -1110000 − 22154000 USD Exact free cash flow: -23264000 USD 2013-01-01 – 2013-12-31: -1110000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 22154000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2013-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -23264000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1110000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312516470022/sgen-20151231.xml#70616 Filing: 000119312516470022 Input fundies:CapitalExpenditure: 22154000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312516470022/sgen-20151231.xml#72902 Filing: 000119312516470022 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 76.14 million Exact value Exact value: -76141000 USD 2014-01-01 – 2014-12-31: -76141000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2014-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -76141000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -76141000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312517050543/sgen-20161231.xml#83148 Filing: 000119312517050543 The citation records this snapshot. The page link may show a newer release later.	−USD 60 million Exact value Exact value: -59999000 USD 2014-01-01 – 2014-12-31: -59999000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2014-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -59999000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59999000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312517050543/sgen-20161231.xml#88035 Filing: 000119312517050543 The citation records this snapshot. The page link may show a newer release later.	USD 17.18 million Exact value Exact value: 17176000 USD 2014-01-01 – 2014-12-31: 17176000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2014-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 17176000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17176000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312517050543/sgen-20161231.xml#88612 Filing: 000119312517050543 The citation records this snapshot. The page link may show a newer release later.	−USD 77.18 million Calculation and evidence -59999000 − 17176000 USD Exact free cash flow: -77175000 USD 2014-01-01 – 2014-12-31: -59999000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 17176000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2014-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -77175000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59999000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312517050543/sgen-20161231.xml#88035 Filing: 000119312517050543 Input fundies:CapitalExpenditure: 17176000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312517050543/sgen-20161231.xml#88612 Filing: 000119312517050543 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 120.49 million Exact value Exact value: -120486000 USD 2015-01-01 – 2015-12-31: -120486000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2015-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -120486000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -120486000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312518046213/sgen-20171231.xml#88664 Filing: 000119312518046213 The citation records this snapshot. The page link may show a newer release later.	−USD 133.2 million Exact value Exact value: -133203000 USD 2015-01-01 – 2015-12-31: -133203000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2015-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -133203000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -133203000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312518046213/sgen-20171231.xml#88047 Filing: 000119312518046213 The citation records this snapshot. The page link may show a newer release later.	USD 13.39 million Exact value Exact value: 13392000 USD 2015-01-01 – 2015-12-31: 13392000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2015-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 13392000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13392000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312518046213/sgen-20171231.xml#91172 Filing: 000119312518046213 The citation records this snapshot. The page link may show a newer release later.	−USD 146.6 million Calculation and evidence -133203000 − 13392000 USD Exact free cash flow: -146595000 USD 2015-01-01 – 2015-12-31: -133203000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 13392000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2015-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -146595000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -133203000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312518046213/sgen-20171231.xml#88047 Filing: 000119312518046213 Input fundies:CapitalExpenditure: 13392000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000119312518046213/sgen-20171231.xml#91172 Filing: 000119312518046213 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 140.11 million Exact value Exact value: -140111000 USD 2016-01-01 – 2016-12-31: -140111000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2016-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -140111000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -140111000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073619000010/sgen-20181231.xml#271247 Filing: 000106073619000010 The citation records this snapshot. The page link may show a newer release later.	−USD 96.97 million Exact value Exact value: -96971000 USD 2016-01-01 – 2016-12-31: -96971000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2016-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -96971000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -96971000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073619000010/sgen-20181231.xml#270609 Filing: 000106073619000010 The citation records this snapshot. The page link may show a newer release later.	USD 27.84 million Exact value Exact value: 27835000 USD 2016-01-01 – 2016-12-31: 27835000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2016-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 27835000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 27835000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073619000010/sgen-20181231.xml#285621 Filing: 000106073619000010 The citation records this snapshot. The page link may show a newer release later.	−USD 124.81 million Calculation and evidence -96971000 − 27835000 USD Exact free cash flow: -124806000 USD 2016-01-01 – 2016-12-31: -96971000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 27835000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2016-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -124806000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -96971000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073619000010/sgen-20181231.xml#270609 Filing: 000106073619000010 Input fundies:CapitalExpenditure: 27835000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073619000010/sgen-20181231.xml#285621 Filing: 000106073619000010 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 125.53 million Exact value Exact value: -125530000 USD 2017-01-01 – 2017-12-31: -125530000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2017-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -125530000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -125530000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073620000006/a10k2019.htm#1636063 Filing: 000106073620000006 The citation records this snapshot. The page link may show a newer release later.	−USD 118.9 million Exact value Exact value: -118900000 USD 2017-01-01 – 2017-12-31: -118900000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2017-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -118900000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -118900000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073620000006/a10k2019.htm#1684290 Filing: 000106073620000006 The citation records this snapshot. The page link may show a newer release later.	USD 28.72 million Exact value Exact value: 28722000 USD 2017-01-01 – 2017-12-31: 28722000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2017-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 28722000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 28722000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073620000006/a10k2019.htm#1698151 Filing: 000106073620000006 The citation records this snapshot. The page link may show a newer release later.	−USD 147.62 million Calculation and evidence -118900000 − 28722000 USD Exact free cash flow: -147622000 USD 2017-01-01 – 2017-12-31: -118900000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 28722000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2017-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -147622000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -118900000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073620000006/a10k2019.htm#1684290 Filing: 000106073620000006 Input fundies:CapitalExpenditure: 28722000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073620000006/a10k2019.htm#1698151 Filing: 000106073620000006 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 222.69 million Exact value Exact value: -222693000 USD 2018-01-01 – 2018-12-31: -222693000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2018-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -222693000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -222693000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073621000012/sgen-20201231.htm#2313049 Filing: 000106073621000012 The citation records this snapshot. The page link may show a newer release later.	−USD 203.54 million Exact value Exact value: -203536000 USD 2018-01-01 – 2018-12-31: -203536000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2018-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -203536000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -203536000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073621000012/sgen-20201231.htm#1613628 Filing: 000106073621000012 The citation records this snapshot. The page link may show a newer release later.	USD 21.22 million Exact value Exact value: 21219000 USD 2018-01-01 – 2018-12-31: 21219000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2018-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 21219000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 21219000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073621000012/sgen-20201231.htm#1627472 Filing: 000106073621000012 The citation records this snapshot. The page link may show a newer release later.	−USD 224.76 million Calculation and evidence -203536000 − 21219000 USD Exact free cash flow: -224755000 USD 2018-01-01 – 2018-12-31: -203536000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 21219000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2018-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -224755000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -203536000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073621000012/sgen-20201231.htm#1613628 Filing: 000106073621000012 Input fundies:CapitalExpenditure: 21219000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073621000012/sgen-20201231.htm#1627472 Filing: 000106073621000012 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 158.65 million Exact value Exact value: -158650000 USD 2019-01-01 – 2019-12-31: -158650000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2019-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -158650000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -158650000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073622000016/sgen-20211231.htm#2134348 Filing: 000106073622000016 The citation records this snapshot. The page link may show a newer release later.	−USD 163.74 million Exact value Exact value: -163737000 USD 2019-01-01 – 2019-12-31: -163737000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2019-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -163737000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -163737000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073622000016/sgen-20211231.htm#1453718 Filing: 000106073622000016 The citation records this snapshot. The page link may show a newer release later.	USD 70.75 million Exact value Exact value: 70753000 USD 2019-01-01 – 2019-12-31: 70753000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2019-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 70753000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 70753000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073622000016/sgen-20211231.htm#1467645 Filing: 000106073622000016 The citation records this snapshot. The page link may show a newer release later.	−USD 234.49 million Calculation and evidence -163737000 − 70753000 USD Exact free cash flow: -234490000 USD 2019-01-01 – 2019-12-31: -163737000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 70753000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2019-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -234490000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -163737000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073622000016/sgen-20211231.htm#1453718 Filing: 000106073622000016 Input fundies:CapitalExpenditure: 70753000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073622000016/sgen-20211231.htm#1467645 Filing: 000106073622000016 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	USD 613.67 million Exact value Exact value: 613670000 USD 2020-01-01 – 2020-12-31: 613670000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2020-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: 613670000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: 613670000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#2223340 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	USD 856.57 million Exact value Exact value: 856568000 USD 2020-01-01 – 2020-12-31: 856568000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2020-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: 856568000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 856568000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1481053 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	USD 82.41 million Exact value Exact value: 82409000 USD 2020-01-01 – 2020-12-31: 82409000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2020-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 82409000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 82409000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1498187 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	USD 774.16 million Calculation and evidence 856568000 − 82409000 USD Exact free cash flow: 774159000 USD 2020-01-01 – 2020-12-31: 856568000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 82409000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2020-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: 774159000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 856568000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1481053 Filing: 000106073623000009 Input fundies:CapitalExpenditure: 82409000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1498187 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 674.47 million Exact value Exact value: -674471000 USD 2021-01-01 – 2021-12-31: -674471000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2021-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -674471000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -674471000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#2222077 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	−USD 499.01 million Exact value Exact value: -499007000 USD 2021-01-01 – 2021-12-31: -499007000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2021-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -499007000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -499007000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1479996 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	USD 52.33 million Exact value Exact value: 52330000 USD 2021-01-01 – 2021-12-31: 52330000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2021-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 52330000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52330000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1497197 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	−USD 551.34 million Calculation and evidence -499007000 − 52330000 USD Exact free cash flow: -551337000 USD 2021-01-01 – 2021-12-31: -499007000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 52330000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2021-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -551337000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -499007000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1479996 Filing: 000106073623000009 Input fundies:CapitalExpenditure: 52330000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1497197 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 610.31 million Exact value Exact value: -610308000 USD 2022-01-01 – 2022-12-31: -610308000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Net Income: -610308000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -610308000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#2220813 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	−USD 453.75 million Exact value Exact value: -453751000 USD 2022-01-01 – 2022-12-31: -453751000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Operating Cash Flow: -453751000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -453751000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1478938 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	USD 77.34 million Exact value Exact value: 77340000 USD 2022-01-01 – 2022-12-31: 77340000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Capital Expenditure: 77340000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 77340000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1496207 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.	−USD 531.09 million Calculation and evidence -453751000 − 77340000 USD Exact free cash flow: -531091000 USD 2022-01-01 – 2022-12-31: -453751000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 77340000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SEATTLE GENETICS INC /WA · 2022-12-31 SEATTLE GENETICS INC /WA (edgar:1060736) Free cash flow: -531091000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:05:06Z Snapshot: 9540879e4a435b6a1b2c1a6d8d3cf0b2587ee55564f062b6438c19a725fa62a6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1060736?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -453751000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1478938 Filing: 000106073623000009 Input fundies:CapitalExpenditure: 77340000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1060736/000106073623000009/sgen-20221231.htm#1496207 Filing: 000106073623000009 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

147 filings · 3,731 latest values · 3,731 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001060736, 1060736, SGEN, edgar:1060736, sgen

Also known as SEAGEN INC., SEATTLE GENETICS INC /WA, Seagen Inc.

SEATTLE GENETICS INC /WA

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation